RELMADA THERAPEUTICS, INC.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2017 | $-0.52 | $-12.63 |
| FY2018 | $-2.86 | $-11.12 |
| FY2019 | $-2.74 | $-9.82 |
| FY2020 | $-3.81 | $-9.17 |
| FY2021 | $-7.16 | $-9.07 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2017 | $-0.52 | $-12.63 |
| FY2018 | $-2.86 | $-11.12 |
| FY2019 | $-2.74 | $-9.82 |
| FY2020 | $-3.81 | $-9.17 |
| FY2021 | $-7.16 | $-9.07 |